Journals / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

The analysis of optical coherence tomography angiographic parameters in patients with and without clinically significant diabetic macular edema

Pages
208–213
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

OCTA could be used as a noninvasive modality to assess and compare the structural and vasculature changes in diabetic patients with or/and w/o CSME.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of our study was to compare the parameters of optical coherence tomography angiography between eyes with clinically significant macular edema (CSME) and without (w/o) CSME in patients diagnosed with diabetic macular edema (DME).
📊
Key Findings & Data:Sixty-eight eyes of 34 patients with DME were included in the cross-sectionally designed study.
💡
Conclusion & Impact:OCTA could be used as a noninvasive modality to assess and compare the structural and vasculature changes in diabetic patients with or/and w/o CSME.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The aim of our study was to compare the parameters of optical coherence tomography angiography between eyes with clinically significant macular edema (CSME) and without (w/o) CSME in patients diagnosed with diabetic macular edema (DME). Sixty-eight eyes of 34 patients with DME were included in the cross-sectionally designed study. The eyes of the patients with DME were divided into 2 groups, including the eyes with CSME and the eyes w/o CSME. Optical coherence tomography (OCTA) parameters, including central macular thickness, superficial and deep capillary plexus, and choriocapillaris flow area were evaluated between these two groups. Eyes with CSME had a thicker central retinal thickness (CRT), (P≤0.001) and worse visual acuity (VA), (P=0.002), and there was a strong negative correlation between CRT and VA among patients with CSME (r=-0.616, P≤0.001). We observed increases in the vessel density (VD) measurements of the superficial fovea (P=0.006) and deep fovea areas (P=0.036), whereas reductions in the VD measurements of other deeper plexuses in the comparison of eyes with CSME and w/o CSME in patients with diagnosis of DME. We did not note significant differences between FAZ metrics. OCTA could be used as a noninvasive modality to assess and compare the structural and vasculature changes in diabetic patients with or/and w/o CSME.

🔖

Cite This Article

DEMİR, M., Akpolat, Ç., USLU, C., ARSLAN, G. D., GÜVEN, D. (2022). The analysis of optical coherence tomography angiographic parameters in patients with and without clinically significant diabetic macular edema. Medicine Science, Cilt: 11 - Sayı: 1, 208–213. https://ajindex.com/articles/413721

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Habib SL, Rojna M. Diabetes and risk of cancer. ISRN Oncol. 2013;2013:583786
  2. Cebeci Z, Kir N. Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant. Diabetes Metab Syndr Obes. 2015;8:555–66
  3. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54
  4. Lang GE. Diabetic macular edema. Ophthalmologica. 2012;227:21–9
  5. Ding J, Wont TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12:346–54
  6. Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopa¬thy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17
  7. Executive Summary. IFD Diabetes Atlas. 7th edition. 2017;23-26
  8. Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. Dev Ophthalmol. 2016;55:137-46
  9. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-36
  10. Campos PR, Rubio SC, García GDM, et al. Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice. Clin Ophthalmol. 2018;12:99-104
  11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–81
  12. Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD008081. 13. de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous. 2015;1:5
  13. Soares M, Neves C, Marques IP, et al. Comparison of diabetic retinopathy classification using fluorescein angiography and optical coherence tomography angiography. Br J Ophthalmol. 2017;101:62–8
  14. Khan HA, Mehmood A, Khan QA, et al. A major review of optical coherence tomography angiography. Expert Rev Ophthalmol. 2017;12:373–85
  15. Guo Y, Camino A, Wang J, et al. A neural network for automated detection of avascular area in OCT angiography. Biomed Opt Express. 2018;9:5147-58
  16. Khadamy J, Abri Aghdam K, Falavarjani KG. An update on optical coherence tomography angiography in diabetic retinopathy. J Ophthalmic Vis Res. 2018;13:487-97
  17. Mathew C, Yunirakasiwi A, Sanjay S. Updates in the management of diabetic macular edema. J Diabetes Res. 2015;2015:794036
  18. Simonett JM, Scarinci F, Picconi F, et al. Early microvascular retinal changes in optical coherence tomography angiography in pa